Mitomycin C and High-Dose 5-Fluorouracil With Folinic Acid as a Therapeutic Option for Heavily Pretreated Patients With Metastatic Colorectal Cancer: Prospective Phase II Trial

Oncologist - United States
doi 10.1634/theoncologist.2014-0029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Mitomycin C Plus 5-Fluorouracil Versus Plasmapheresis and the Same Chemotherapy in Metastatic Colorectal Cancer: A Prospective Randomized Trial

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

High-Dose Folinic Acid and 5-Fluorouracil Bolus and Continuous Infusion in Advanced Colorectal Cancer: Poor Response Rate in Unselected Patients

British Journal of Cancer
Cancer ResearchOncology
1995English

Induction With Mitomycin C, Doxorubicin, Cisplatin and Maintenance With Weekly 5-Fluorouracil, Leucovorin for Treatment of Metastatic Nasopharyngeal Carcinoma: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
1999English

A Phase II Randomised Trial of 5-Fluorouracil With or Without Interferon Alpha-2a in Advanced Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1996English

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Oxaliplatin With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFOX 4) as First-Line Therapy for Patients With Metastatic Colorectal Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2004English

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Clinical Colorectal Cancer
OncologyGastroenterology
2015English

Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: A Prospective Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2014English

A Phase II Study to Evaluate Lenalidomide in Combination With Metronomic-Dose Cyclophosphamide in Patients With Heavily Pretreated Classical Hodgkin Lymphoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy